S. 3921 (111th): Ethical Pathway Act of 2010
Sep 29, 2010
111th Congress, 2009–2010
Died in a previous Congress
This bill was introduced on September 29, 2010, in a previous session of Congress, but was not enacted.
Bernard “Bernie” Sanders
Senator from Vermont
Read Text »
Last Updated: Sep 29, 2010
Length: 10 pages
About the bill
- Full Title
A bill to ensure that rules for the approval of pharmaceutical and biological products do not require violations of medical ethics in the testing of products in humans and vertebrate animals.
Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.
Referred to Committee
Last Action: Aug 2, 2012
- What is a bill?
The “S.” in “S. 3921” means this is a Senate bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The bill’s title was written by its sponsor.
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no votes related to this bill.
- Subject Areas
- Find Similar Bills
Search for similar bills.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2015). S. 3921 — 111th Congress: Ethical Pathway Act of 2010. Retrieved from https://www.govtrack.us/congress/bills/111/s3921
“S. 3921 — 111th Congress: Ethical Pathway Act of 2010.” www.GovTrack.us. 2010. March 28, 2015 <https://www.govtrack.us/congress/bills/111/s3921>
|title=S. 3921 (111th)
|accessdate=March 28, 2015
|author=111th Congress (2010)
|date=September 29, 2010
|quote=Ethical Pathway Act of 2010